BindingDB logo
myBDB logout

BDBM275795 5-chloro-4-(3-chloro- 4-(trifluoromethoxy) phenoxy)-N-(N,N- dimethylsulfamoyl)- 2-fluorobenzamide::US10071957, Example 12

SMILES: CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(Oc2ccc(OC(F)(F)F)c(Cl)c2)cc1F

InChI Key: InChIKey=CBBIFGUXOMJZQD-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 275795   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM275795
PNG
(5-chloro-4-(3-chloro- 4-(trifluoromethoxy) phenoxy...)
Show SMILES CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(Oc2ccc(OC(F)(F)F)c(Cl)c2)cc1F
Show InChI InChI=1S/C16H12Cl2F4N2O5S/c1-24(2)30(26,27)23-15(25)9-6-11(18)14(7-12(9)19)28-8-3-4-13(10(17)5-8)29-16(20,21)22/h3-7H,1-2H3,(H,23,25)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 218n/an/an/an/a7.425



GENENTECH, INC.; XENON PHARMACEUTICALS INC.

US Patent


Assay Description
Preparation of membranes containing recombinantly expressed sodium channels: Frozen recombinant cell pellets were thawed on ice and diluted to 4 time...


US Patent US10071957 (2018)


BindingDB Entry DOI: 10.7270/Q2J1056P
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM275795
PNG
(5-chloro-4-(3-chloro- 4-(trifluoromethoxy) phenoxy...)
Show SMILES CN(C)S(=O)(=O)NC(=O)c1cc(Cl)c(Oc2ccc(OC(F)(F)F)c(Cl)c2)cc1F
Show InChI InChI=1S/C16H12Cl2F4N2O5S/c1-24(2)30(26,27)23-15(25)9-6-11(18)14(7-12(9)19)28-8-3-4-13(10(17)5-8)29-16(20,21)22/h3-7H,1-2H3,(H,23,25)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 41n/an/an/an/a7.2n/a



GENENTECH, INC.; XENON PHARMACEUTICALS INC.

US Patent


Assay Description
Patch voltage clamp electrophysiology allows for the direct measurement and quantification of block of voltage-gated sodium channels (NaV's), and...


US Patent US10071957 (2018)


BindingDB Entry DOI: 10.7270/Q2J1056P
More data for this
Ligand-Target Pair